IGF1 and colorectal cancer: It further reduces IL-8 expression and modulates pathways associated with inflammation, UV-induced mutagenesis, and insulin resistance by targeting insulin-like growth factor-1 (IGF-1) and tumor necrosis factor alpha (TNF-α), particularly relevant to colorectal cancer [17].